MOLECULAR PARTNERS AG (MOLN) Insider Trading Disclosures
MOLECULAR PARTNERS AG (MOLN) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: MOLN
CIK: 1745114
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG AG
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerSimon Studer
Audit LocationZurich, Switzerland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-08-25 | 2026-06-30 | 6-K | 0001745114-26-000028 | View SEC Doc Filr Page |
| 6-K | 2026-07-20 | 2026-07-16 | FORM 6-K | 0001171843-26-004758 | View SEC Doc Filr Page |
| 6-K | 2026-07-07 | 2026-07-06 | FORM 6-K | 0001171843-26-004488 | View SEC Doc Filr Page |
| 6-K | 2026-07-02 | 2026-07-02 | FORM 6-K | 0001171843-26-004433 | View SEC Doc Filr Page |
| S-8 | 2026-06-24 | — | S-8 | 0001745114-26-000023 | View SEC Doc Filr Page |
| 6-K | 2026-06-01 | 2026-05-30 | FORM 6-K | 0001171843-26-003818 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-03-31 | 6-K | 0001745114-26-000019 | View SEC Doc Filr Page |
| 6-K | 2026-05-01 | 2026-05-01 | FORM 6-K | 0001171843-26-002920 | View SEC Doc Filr Page |
| 6-K | 2026-04-14 | 2026-04-14 | FORM 6-K | 0001171843-26-002441 | View SEC Doc Filr Page |
| 6-K | 2026-03-30 | 2026-03-31 | 6-K | 0001745114-26-000015 | View SEC Doc Filr Page |
| 6-K | 2026-03-13 | 2026-03-12 | FORM 6-K | 0001171843-26-001557 | View SEC Doc Filr Page |
| 6-K | 2026-03-12 | 2025-12-31 | 6-K | 0001745114-26-000012 | View SEC Doc Filr Page |
| 20-F | 2026-03-12 | 2025-12-31 | 20-F | 0001745114-26-000009 | View SEC Doc Filr Page |
| 6-K | 2026-02-02 | 2026-02-02 | FORM 6-K | 0001171843-26-000552 | View SEC Doc Filr Page |
| 6-K | 2026-01-12 | 2026-01-11 | FORM 6-K | 0001171843-26-000214 | View SEC Doc Filr Page |
| 6-K | 2025-12-08 | 2025-12-07 | FORM 6-K | 0001171843-25-007798 | View SEC Doc Filr Page |
| 6-K | 2025-11-12 | 2025-11-12 | FORM 6-K | 0001171843-25-007219 | View SEC Doc Filr Page |
| 6-K | 2025-10-30 | 2025-09-30 | 6-K | 0001745114-25-000037 | View SEC Doc Filr Page |
| 6-K | 2025-08-25 | 2025-06-30 | 6-K | 0001745114-25-000031 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-07-17 | — | SCHEDULE 13G Filing | 0000861177-25-000007 | View SEC Doc Filr Page |
| S-8 | 2025-06-25 | — | S-8 | 0001745114-25-000026 | View SEC Doc Filr Page |
| 6-K | 2025-06-12 | 2025-06-12 | 6-K | 0001745114-25-000022 | View SEC Doc Filr Page |
| 6-K | 2025-05-15 | 2025-03-31 | 6-K | 0001745114-25-000020 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2025-05-02 | — | SCHEDULE 13G Filing | 0000899140-25-000572 | View SEC Doc Filr Page |
| 6-K | 2025-04-29 | 2025-04-29 | 6-K | 0001745114-25-000016 | View SEC Doc Filr Page |